[EN] SUSTAINED RELEASE CANNABINOID MEDICAMENTS<br/>[FR] MÉDICAMENTS DE CANNABINOÏDE À LIBÉRATION PROLONGÉE
申请人:STEADY SLEEP RX CO INC
公开号:WO2011063164A2
公开(公告)日:2011-05-26
The present invention provides a medicament which results in delivery of a therapeutic level of one or more cannabinoids during a clinically relevant therapeutic window. The therapeutic window is a longer window than provided by an immediate release medicament such as Marinol containing an equivalent amount of the cannabinoid. Oral administration of the present compositions provides therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of treating cannabinoid-sensitive disorders.